RT Journal Article
SR Electronic
T1 741 TWT-101: a first-in-clinic study of CFI-402411, a hematopoietic progenitor Kinase-1 (HPK1) inhibitor, as single agent or combined with pembrolizumab in subjects with advanced solid malignancies
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A835
OP A835
DO 10.1136/jitc-2023-SITC2023.0741
VO 11
IS Suppl 1
A1 Papadopoulos, Kyriakos P
A1 Laurie, Scott A
A1 Spira, Alexander
A1 Fu, Siqing
A1 Hamilton, Erika
A1 Ma, Brigette
A1 Wang, Judy S
A1 Sharma, Manish
A1 Chu, Quincy
A1 Spreafico, Anna
A1 Bray, Mark R
A1 Chen, Dih-Yih
A1 Roberts-Thomson, Emily
A1 Sidhu, Roger
A1 Hamid, Omid
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A835.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.